KR20130039726A - 대사 증후군의 치료를 위한 글루코만난, 잔탄 검 및 알긴산염을 포함하는 식품 - Google Patents

대사 증후군의 치료를 위한 글루코만난, 잔탄 검 및 알긴산염을 포함하는 식품 Download PDF

Info

Publication number
KR20130039726A
KR20130039726A KR1020127026489A KR20127026489A KR20130039726A KR 20130039726 A KR20130039726 A KR 20130039726A KR 1020127026489 A KR1020127026489 A KR 1020127026489A KR 20127026489 A KR20127026489 A KR 20127026489A KR 20130039726 A KR20130039726 A KR 20130039726A
Authority
KR
South Korea
Prior art keywords
vfc
alginate
xanthan gum
dietary fiber
glucomannan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020127026489A
Other languages
English (en)
Korean (ko)
Inventor
롤란드 제이. 갈러
마이클 리온
시몬 우드
크리스토퍼 존 로슨
Original Assignee
이노보바이오로직 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이노보바이오로직 인코포레이티드 filed Critical 이노보바이오로직 인코포레이티드
Publication of KR20130039726A publication Critical patent/KR20130039726A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A23L29/27—Xanthan not combined with other microbial gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/723—Xanthans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020127026489A 2010-03-10 2011-03-10 대사 증후군의 치료를 위한 글루코만난, 잔탄 검 및 알긴산염을 포함하는 식품 Ceased KR20130039726A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US31263010P 2010-03-10 2010-03-10
US61/312,630 2010-03-10
US35765810P 2010-06-23 2010-06-23
US61/357,658 2010-06-23
PCT/CA2011/000260 WO2011109900A1 (en) 2010-03-10 2011-03-10 Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders

Publications (1)

Publication Number Publication Date
KR20130039726A true KR20130039726A (ko) 2013-04-22

Family

ID=44560211

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127026489A Ceased KR20130039726A (ko) 2010-03-10 2011-03-10 대사 증후군의 치료를 위한 글루코만난, 잔탄 검 및 알긴산염을 포함하는 식품

Country Status (12)

Country Link
US (1) US20110223192A1 (enExample)
EP (1) EP2544696B1 (enExample)
JP (3) JP2013525269A (enExample)
KR (1) KR20130039726A (enExample)
CN (1) CN102892421A (enExample)
AU (2) AU2011226708B2 (enExample)
BR (1) BR112012022799B1 (enExample)
CA (2) CA2791418C (enExample)
NZ (1) NZ602249A (enExample)
RU (1) RU2553348C2 (enExample)
SG (1) SG183543A1 (enExample)
WO (1) WO2011109900A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160001935A (ko) 2014-06-30 2016-01-07 원광대학교산학협력단 블랙 커런트 추출물을 유효성분으로 함유하는 대사증후군의 예방, 개선 또는 치료를 위한 조성물

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010039734A1 (de) * 2010-08-25 2012-03-01 Bayer Materialscience Aktiengesellschaft Katalysator und Verfahren zur Herstellung von Chlor durch Gasphasenoxidation
GB201110672D0 (en) * 2011-06-23 2011-08-10 M I Drilling Fluids Uk Ltd Wellbore fluid
TWI469785B (zh) * 2012-04-25 2015-01-21 Inovobiologic Inc 用於治療代謝性疾病之膳食纖維組成物
RU2672594C2 (ru) * 2013-07-01 2018-11-16 Юниверсити Оф Саутерн Калифорния Состояние воздержания от пищи в качестве диетического лечения диабета
CN104277130A (zh) * 2013-07-02 2015-01-14 中国科学院上海药物研究所 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途
CN103604884B (zh) * 2013-11-21 2015-10-28 南京工业大学 一种检测海藻生物质内还原性糖类物质的方法
EP3082466B1 (en) * 2013-12-18 2019-08-21 Thylabisco AB Use of thylakoids to reduce the urge for palatable food
CN104391049B (zh) * 2014-09-20 2017-03-22 鄂尔多斯市中轩生化股份有限公司 黄原胶微量溶剂残留量的检测方法
SMT202300091T1 (it) * 2014-11-26 2023-05-12 Omega Pharma Innovation And Dev Nv Composizione di fibre dietetica
ES2857557T3 (es) * 2015-01-26 2021-09-29 Kaleido Biosciences Inc Compuestos terapéuticos de glicano y métodos relacionados de los mismos
CA3224535A1 (en) * 2016-01-12 2017-07-20 University Of Southern California Use of long-term fasting mimicking as dietary treatment for multiple myeloma and other cancers
US10485253B2 (en) 2017-08-21 2019-11-26 Mustapha Benmoussa Method of microalgal biomass processing for high-value chemicals production, the resulting composition of butyrogenic algal slowly fermenting dietary fiber, and a way to improve colon health using a slowly fermenting butyrogenic algal dietary fiber
EP3827027A4 (en) 2018-07-23 2022-04-27 Nutragenom, LLC COMPOSITION AND METHODS FOR GENERATE AND MAINTAIN MOLECULAR HYDROGEN (H2) IN AQUEOUS SYSTEMS
CN110412157A (zh) * 2019-07-17 2019-11-05 广州金评检测研究院有限公司 一种烟酰胺原料中烟酸的测定方法
JP7412759B2 (ja) * 2020-04-16 2024-01-15 松谷化学工業株式会社 水溶性食物繊維のエネルギー量の簡便な測定方法
CN112933105A (zh) * 2021-02-10 2021-06-11 浙江工业大学 甘露葡萄糖醛酸多（寡）糖及硫酸化衍生物在制备治疗非酒精性脂肪肝药物中的应用
CN112782321A (zh) * 2021-03-09 2021-05-11 上海市质量监督检验技术研究院 一种快速检测纺织品中维生素e含量的测定方法
CN117665192A (zh) * 2023-06-30 2024-03-08 辰欣药业股份有限公司 一种特殊医学用途全营养配方乳剂食品中钾、钙、钠、镁的测定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0683118B2 (ja) * 1988-01-19 1994-10-19 日本電気株式会社 直流終端回路
JPH02245148A (ja) * 1989-03-17 1990-09-28 Unie Koroido Kk グルコマンナンの凝固方法及びこれに用いる組成物
US5460957A (en) * 1992-04-28 1995-10-24 Maruha Corporation Calcium alginate oligosaccharide and method for producing the same from potassium or sodium alginate
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
GB0406013D0 (en) * 2004-03-17 2004-04-21 Chiron Srl Analysis of saccharide vaccines without interference
US8062686B2 (en) * 2005-04-12 2011-11-22 InovoBiologics, Inc. Dietary supplement, and methods of use
US8597709B2 (en) * 2005-04-12 2013-12-03 Inovobiologic Inc. Dietary supplement and methods of use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160001935A (ko) 2014-06-30 2016-01-07 원광대학교산학협력단 블랙 커런트 추출물을 유효성분으로 함유하는 대사증후군의 예방, 개선 또는 치료를 위한 조성물

Also Published As

Publication number Publication date
BR112012022799A2 (pt) 2021-03-23
AU2014213536A1 (en) 2014-09-04
US20110223192A1 (en) 2011-09-15
JP2013525269A (ja) 2013-06-20
JP2017074072A (ja) 2017-04-20
AU2011226708B2 (en) 2015-04-02
CA2791418A1 (en) 2011-09-15
JP2015083604A (ja) 2015-04-30
CA2791418C (en) 2016-07-05
NZ602249A (en) 2014-10-31
AU2011226708A1 (en) 2012-09-27
EP2544696B1 (en) 2019-05-22
CN102892421A (zh) 2013-01-23
WO2011109900A1 (en) 2011-09-15
SG183543A1 (en) 2012-10-30
RU2012142237A (ru) 2014-04-20
BR112012022799B1 (pt) 2021-11-30
RU2553348C2 (ru) 2015-06-10
EP2544696A1 (en) 2013-01-16
EP2544696A4 (en) 2013-08-21
CA2859055A1 (en) 2011-09-15

Similar Documents

Publication Publication Date Title
EP2544696B1 (en) Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders
Dai et al. Classification and regulatory perspectives of dietary fiber
Panahi et al. β-Glucan from two sources of oat concentrates affect postprandial glycemia in relation to the level of viscosity
Rose et al. Influence of dietary fiber on inflammatory bowel disease and colon cancer: importance of fermentation pattern
Hu et al. Artificial simulated saliva, gastric and intestinal digestion of polysaccharide from the seeds of Plantago asiatica L.
Shah et al. Health benefits of konjac glucomannan with special focus on diabetes
Zhao et al. Digestibility of fucosylated glycosaminoglycan from sea cucumber and its effects on digestive enzymes under simulated salivary and gastrointestinal conditions
Immerstrand et al. Effects of oat bran, processed to different molecular weights of β-glucan, on plasma lipids and caecal formation of SCFA in mice
Adams et al. Interactions of dietary fibre with nutritional components on gut microbial composition, function and health in monogastrics
JP4286254B2 (ja) グリセミック指数低減用組成物及び食品
Guice et al. Microbial inulinase promotes fructan hydrolysis under simulated gastric conditions
AU2007309225A1 (en) Method of preventing or treating metabolic syndrome
EP2936999B1 (en) Anticholesteremic fibre combination
Thibault et al. Sugar beet fiber: production, composition, physicochemical properties, physiological effects, safety, and food applications
TWI630875B (zh) 用於延遲代謝症候群之發作及／或降低代謝症候群之嚴重性的方法
Haskå et al. A water-soluble fraction from a by-product of wheat increases the formation of propionic acid in rats compared with diets based on other by-product fractions and oligofructose
Yamatoya et al. Effects of xyloglucan on lipid metabolism
Ralet et al. Sugar beet fiber: Production, characteristics, food applications, and physiological benefits
Yao et al. Non-digestible Polysaccharides
Amer et al. Effect of apple-lite contained of apple fibers and apple gel pectin on body weight, lipid profiles, kidney function and histological structure of kidney in male albino rats
Lyon Dietary Fiber
Yongliang et al. Modulation of fasting blood glucose by raw banana powder in alloxan-induced diabetic rats
Panahi The effect of oat beta-glucan on glycemia and blood lipid risk factors for cardiovascular disease
Anson et al. Bioprocessed wheat bran in whole-meal breads increases colonic butyrate production

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20121010

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20160308

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20170418

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20180227

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20170418

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I